3,5-Di-O-galloylshikimic acid
3,5-Di-O-galloylshikimic acid is a naturally derived phenolic acid compound with potential antiviral and hepatoprotective activities. 3,5-Di-O-galloylshikimic acid inhibits HIV replication, inactivates HIV viral particles and blocks virus-cell interactions. 3,5-Di-O-galloylshikimic acid has the potential to bind simultaneously to SARS-CoV-2 main protease (Mpro) and human ACE2 receptor. 3,5-Di-O-galloylshikimic acid can be used in studies related to coronavirus disease 2019 (COVID-19), acquired immunodeficiency syndrome (AIDS) and acute liver injury.
For research use only. We do not sell to patients.
- CAS No.: 95753-52-9
- Formula: C21H18O13
- Molecular Weight:478.36
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Endogenous Metabolite Isoforms
More
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | ED50 |
>10 μg/mL
Compound: 18
|
Cytotoxicity against human A549 cells by tetrazolium salt-based colorimetric assay
Cytotoxicity against human A549 cells by tetrazolium salt-based colorimetric assay
|
[PMID: 1431932] |
| HCT-8 | ED50 |
>10 μg/mL
Compound: 18
|
Cytotoxicity against human HCT8 cells by tetrazolium salt-based colorimetric assay
Cytotoxicity against human HCT8 cells by tetrazolium salt-based colorimetric assay
|
[PMID: 1431932] |
| KB | ED50 |
>10 μg/mL
Compound: 18
|
Cytotoxicity against human KB cells by tetrazolium salt-based colorimetric assay
Cytotoxicity against human KB cells by tetrazolium salt-based colorimetric assay
|
[PMID: 1431932] |
| TE-671 | ED50 |
>10 μg/mL
Compound: 18
|
Cytotoxicity against human TE671 cells by tetrazolium salt-based colorimetric assay
Cytotoxicity against human TE671 cells by tetrazolium salt-based colorimetric assay
|
[PMID: 1431932] |
In Vitro
3,5-Di-O-galloylshikimic acid binds to human ACE2 (docking score = -11.16 kcal/mol, MM-GBSA binding free energy = -51.7 kcal/mol) and SARS-CoV-2 main protease (Mpro) (docking score = -10.3 kcal/mol, MM-GBSA binding free energy = -35.09 kcal/mol) according to molecular docking results[1].
3,5-Di-O-galloylshikimic acid (compound 2) (10-200 μM; 3 days) inhibits HIV replication in infected H9 lymphocytes with an inhibition rate of 97%, and exhibits only extremely low cytotoxicity at concentrations up to 50 μM[2].
3,5-Di-O-galloylshikimic acid exerts the strongest inhibitory effect on HIV replication in H9 lymphocytes when present during the virus-cell infection stage, and its activity is enhanced when pre-incubated with virions compared to post-infection treatment[2].
3,5-di-O-galloylshikimic acid (DGSA) is the primary metabolite synthesized in calli of Opuntia ficus-indica, Opuntia grandiflora and Opuntia streptacantha[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 95753-52-9
-
Molecular Weight 478.36
-
Formula C21H18O13
-
SMILES
O(C(=O)C1=CC(O)=C(O)C(O)=C1)[C@H]2[C@H](O)[C@H](OC(=O)C3=CC(O)=C(O)C(O)=C3)C=C(C(O)=O)C2
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)